Prostaglandin E1 and the ,B-adrenergic hormone I-isoproterenol stimulated cyclic AMP formation in both nucleated and enucleated myeloid leukemic cells that could be induced to differentiate normally to mature cells by the macrophage-and granulocyte-inducing protein MGI (MGI+D+ cells). Enucleated as well as nucleated MGI+D+ cells also desensitized Results on the cellular effects of dibutyryl cyclic AMP (cAMP) and the process of reverse transformation have led to the hypothesis that cytoskeletal components regulate the transfer of information from the cell membrane to the nucleus and that disorganization of these structures can lead to abnormal cell behavior (1-4). Study of some surface receptor-mediated responses (5-7) has also shown that the activity of surface-bound cytoskeletal components can regulate the dynamics of surface receptors that may be required for information transfer from the cell membrane (5). The altered growth pattern in some cell types can be associated with changes in the receptor binding of compounds such as epidermal growth factor (8), insulin (9), or catecholamines (10). However, a crucial point also to be considered is that abnormal cell growth and differentiation may reflect lesions in postbinding events that control the initiation and termination of hormone response and hormone desensitization. Hormone-regulated cAMP formation by surface-bound adenylate cyclase is the result of an interaction between this enzyme and at least two other components, the hormone receptor and the guanyl nucleotide binding site (11)(12)(13)(14)(15)(16)(17) (18), did not show this sensitivity to antitubulin compounds (19). Therefore, the possibility that lack of desensitization reflects a general abnormality of cytoskeletal function that may also affect the cell response to other hormones was studied. The present studies include the use of enucleation to determine the extranuclear nature of hormone desensitization and the role of cytoskeletal structures in the control of hormone response in enucleated cells.
MATERIALS AND METHODSThe leukemic cells used were clones of mouse myeloid leukemic cells isolated from a spontaneous or x-irradiation-induced myeloid leukemias as described (20). The cell clones 11 and 7-M18 were MGI+D+ and clones 1 and 6 were MGI-D-, based on their ability to be induced to differentiate in culture by the macrophage-and granulocyte-inducing protein MGI (20,21). Cells were cultured in Eagle's medium with a 4-fold increased concentration of amino acids and vitamins (H-21, GIBCO) and 10% inactivated fetal calf serum (18). Three or 4 days after seeding, the cells were collected, counted, and preincubated for 20 min at 107 cells per ml of culture medium containing 0.5 mM of the potent phosphodiesterase inhibitor RO-20-1724/1 (kindly donated by Hoffmann-La Roche) with or without 1 ,g of vinblastine sulfate (Ely Lilly), colchicine (Sigma), or cytochalasin B (Aldrich) per ml. Prostaglandin E1 (PGE1) (Sigma) was then added at the indicated concentration. Samples were collected before or...